Featured Trials

As an NCI-designated cancer center, MUSC Hollings Cancer Center offers clinical trials and therapies not available elsewhere in the state. Below are some of the newest and most promising clinical trials that are currently open to patients. 

Cervical Cancer Trial

January is National Cervical Cancer Awareness Month. Adobe Stock image

Hollings is enrolling patients in an ongoing trial that seeks to answer the question of whether adding immunotherapy to radiation treatment improves outcomes for patients with advanced cervical cancer. This trial represents some of the breakthroughs made in cervical cancer in recent years. Hollings will soon open enrollment for other cervical cancer trials.

TMIST Breast Cancer Trial

Dag Pavic with breast imaging device

Hollings is enrolling patients in a national clinical trial aimed at improving breast cancer screenings and treatment options for women with, and without, health insurance. The trial, called Tomosynthesis Mammographic Imaging Screening Trial (TMIST), will provide insights into which type of screening is best and how to improve future breast cancer care.

Lung-MAP Trial

Dr. John Wrangle

A bench-to-bedside-pioneered lung cancer immunology developed at Hollings is included in the national Lung-MAP clinical trial, which is currently enrolling patients at Hollings. The combination immunotherapy developed at Hollings will be offered as a treatment in the unmatched arm, which comprises patients with tumors that do not have mutations targetable with a drug, as opposed to a treatment arm.

COMPPARE Prostate Cancer Trial

Dr David Marshall looks at a computer screen in an operating room

Hollings is enrolling patients in a national clinical trial to help to determine the best, most cost-effective approach for treating prostate cancer through radiation therapy. Known as the COMPPARE study, the trial will compare the quality of life, side effects and cure rates for prostate cancer patients who are treated with either photon therapy or proton therapy.

Clinical Trials Search

Our patients have access to over 200 clinical trials that target virtually every type of cancer.